CIN tumors can be recognized by the accumulation of mutations in tumor-suppressor genes (i.e., transforming growth factor beta receptor 2 (TGFRII), Insulin-like growth factor 2 receptor (IGF2R) and Bcl-2-associated X protein (BAX)). The gene discussed is IGF2R; the disease is neoplasm.